hrp0097p2-258 | Late Breaking | ESPE2023

Long-term Safety and Effectiveness of Growth Hormone in Pediatric Patients with Growth Disorders in Korea: A 10-Year Interim Analysis of the LG Growth Study

Sang Lee Hae , Chung Sochung , Rhie Young-Jun , Hyun Kim Jae , Chae Hyun-Wook , Ho Choi Jin , Ah Lee Young , Mi Kim Yoo , Tae Hwang Il

Objectives: This study aimed to evaluate the safety and effectiveness of rhGH treatment, using specific products (Eutropin®, Eutropin®Pen, Eutropin®AQ, Eutropin®Plus and Eutropin®SPen; LG Chem, Ltd.), in pediatric patients with growth disorders in Korea.Methods: Among the patients who enrolled in LGS (2012–2022, n=5,120), patients received at least one injection of rhGH were included fo...

hrp0098p2-361 | Late Breaking | ESPE2024

Assessment of Growth Hormone Treatment in Korean Pediatric Growth Disorders: 11-Year Interim Analysis from the LG Growth Study

Hee Hong Yong , Kim Jaehyun , Chae Hyun-Wook , Ah Lee Young , Sang Lee Hae , Mi Kim Yoo , Hye Kim Ja , Bae Ahn Moon , Rhie Young-Jun

Objectives: This study aim ed to evaluate the safety and effectiveness of recombinant human growth hormone (rhGH) treatment, using specific products (Eutropin®, Eutropin®Pen, Eutropin®AQ, Eutropin®Plus and Eutropin®SPen; LG Chem, Ltd.), in pediatric patients with growth disorders in Korea.Methods: The safety analysis included all eligible patients who received at least one dose of rhGH. The effectiven...